Chu‐Yen Chien

426 total citations
12 papers, 314 citations indexed

About

Chu‐Yen Chien is a scholar working on Cell Biology, Molecular Biology and Immunology. According to data from OpenAlex, Chu‐Yen Chien has authored 12 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cell Biology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Chu‐Yen Chien's work include Endoplasmic Reticulum Stress and Disease (5 papers), Autophagy in Disease and Therapy (3 papers) and Pancreatic function and diabetes (3 papers). Chu‐Yen Chien is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (5 papers), Autophagy in Disease and Therapy (3 papers) and Pancreatic function and diabetes (3 papers). Chu‐Yen Chien collaborates with scholars based in Taiwan. Chu‐Yen Chien's co-authors include Yi‐Shing Shieh, Chia‐Chen Hsu, Chi‐Fu Chiang, Shyun-Yeu Liu, Yu–Fu Su, Shine‐Gwo Shiah, Ting‐Ting Chao, Kuo‐Chou Chiu, Chien-Hsing Lee and Yi‐Jen Hung and has published in prestigious journals such as PLoS ONE, American Journal of Physiology-Renal Physiology and Oncotarget.

In The Last Decade

Chu‐Yen Chien

12 papers receiving 312 citations

Peers

Chu‐Yen Chien
Louise King Australia
Yaqi Xing China
Lihui Ni China
Jee Hyun Rho South Korea
Louise King Australia
Chu‐Yen Chien
Citations per year, relative to Chu‐Yen Chien Chu‐Yen Chien (= 1×) peers Louise King

Countries citing papers authored by Chu‐Yen Chien

Since Specialization
Citations

This map shows the geographic impact of Chu‐Yen Chien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu‐Yen Chien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu‐Yen Chien more than expected).

Fields of papers citing papers by Chu‐Yen Chien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chu‐Yen Chien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu‐Yen Chien. The network helps show where Chu‐Yen Chien may publish in the future.

Co-authorship network of co-authors of Chu‐Yen Chien

This figure shows the co-authorship network connecting the top 25 collaborators of Chu‐Yen Chien. A scholar is included among the top collaborators of Chu‐Yen Chien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chu‐Yen Chien. Chu‐Yen Chien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Su, Sheng‐Chiang, Yi‐Jen Hung, Fu‐Huang Lin, et al.. (2022). Circulating protein disulfide isomerase family member 4 is associated with type 2 diabetes mellitus, insulin sensitivity, and obesity. Acta Diabetologica. 59(8). 1001–1009. 4 indexed citations
2.
Su, Sheng‐Chiang, Chu‐Yen Chien, Chung‐Cheng Chen, et al.. (2022). PDIA4, a novel ER stress chaperone, modulates adiponectin expression and inflammation in adipose tissue. BioFactors. 48(5). 1060–1075. 13 indexed citations
3.
Chien, Chu‐Yen, Chung‐Cheng Chen, Chia‐Chen Hsu, et al.. (2021). YAP-Dependent BiP Induction Is Involved in Nicotine-Mediated Oral Cancer Malignancy. Cells. 10(8). 2080–2080. 15 indexed citations
4.
Chien, Chu‐Yen, Chung‐Cheng Chen, Chien‐Hsing Lee, et al.. (2021). Dysregulation of the miR-30a/BiP axis by cigarette smoking accelerates oral cancer progression. Cancer Cell International. 21(1). 578–578. 8 indexed citations
5.
Chen, Chung‐Cheng, Chu‐Yen Chien, Chia‐Chen Hsu, et al.. (2021). Obesity-associated leptin promotes chemoresistance in colorectal cancer through YAP-dependent AXL upregulation.. PubMed. 11(9). 4220–4240. 12 indexed citations
6.
Hsu, Chia‐Chen, Kuo‐Yang Tsai, Yu–Fu Su, et al.. (2020). α7-Nicotine acetylcholine receptor mediated nicotine induced cell survival and cisplatin resistance in oral cancer. Archives of Oral Biology. 111. 104653–104653. 20 indexed citations
7.
Hsu, Chia‐Chen, Yu–Fu Su, Kuo‐Yang Tsai, et al.. (2020). Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy. Cancer Cell International. 20(1). 300–300. 11 indexed citations
8.
Su, Sheng‐Chiang, Yi‐Jen Hung, Yi‐Shing Shieh, et al.. (2019). Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE/ERK/NF-κB signaling pathways. Journal of Biomedical Science. 26(1). 68–68. 43 indexed citations
9.
Chiang, Chi‐Fu, Ting‐Ting Chao, Yu–Fu Su, et al.. (2017). Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling. Oncotarget. 8(13). 20706–20718. 141 indexed citations
10.
Chien, Chu‐Yen, Yi‐Jen Hung, Yi‐Shing Shieh, et al.. (2017). A novel potential biomarker for metabolic syndrome in Chinese adults: Circulating protein disulfide isomerase family A, member 4. PLoS ONE. 12(6). e0179963–e0179963. 16 indexed citations
11.
Lee, Chien-Hsing, Chi‐Fu Chiang, Chu‐Yen Chien, et al.. (2017). Estrogen modulates vascular smooth muscle cell function through downregulation of SIRT1. Oncotarget. 8(66). 110039–110051. 24 indexed citations
12.
Lee, Chien-Hsing, Yi‐Jen Hung, Yi‐Shing Shieh, et al.. (2016). Cilostazol inhibits uremic toxin–induced vascular smooth muscle cell dysfunction: role of Axl signaling. American Journal of Physiology-Renal Physiology. 312(3). F398–F406. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026